China SXT Pharmaceuticals Bolsa (NASDAQ: SXTC)

Últimas noticias sobre China SXT Pharmaceuticals (NASDAQ:SXTC) Bolsa

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.

China SXT Pharmaceuticals, Inc. - Common Stock

China SXT Pharmaceuticals Inc

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Compass Point analyst Giuliano Bologna initiated coverage on New Fortress Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>) with a Buy rating and announced a price target of $8.5. New Fortress Energy shares closed at $3.32 on Monday. <a href="https://www.benzinga.com/quote/NFE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Saket Kalia initiated coverage on Omada Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMDA#NASDAQ">OMDA</a>) with an Overweight rating and announced a price target of $21. Omada Health shares closed at $18.30 on Monday. <a href="https://www.benzinga.com/quote/OMDA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wolfe Research analyst Andy Chen initiated coverage on Verona Pharma plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNA#NASDAQ">VRNA</a>) with an Outperform rating and announced a price target of $170. Verona Pharma shares closed at $94.58 on Monday. <a href="https://www.benzinga.com/quote/VRNA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Maxim Group analyst Thomas Forte initiated coverage on Fossil Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOSL#NASDAQ">FOSL</a>) with a Buy rating and announced a price target of $5. Fossil Group shares closed at $1.48 on Monday. <a href="https://www.benzinga.com/quote/FOSL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler analyst Peter Keith initiated coverage on Rollins, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROL#NYSE">ROL</a>) with an Overweight rating and announced a price target of $70. Rollins shares closed at $56.42 on Monday. <a href="https://www.benzinga.com/quote/ROL/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying ROL stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/ROL/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="564" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01125038/image-1-3-1024x564.png" alt="" class="wp-image-969017" style="width:568px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01125038/image-1-3-1024x564.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01125038/image-1-3-300x165.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01125038/image-1-3-768x423.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01125038/image-1-3.png 1137w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46192054/cramer-backs-this-mining-giant-after-1-6b-bet">Cramer Backs This Mining Giant After $1.6B Bet</a></li>
</ul>
Photo via Shutterstock

Initiation

Markets

Analyst Ratings

Trading Ideas

FOSL

OMDA

VRNA

This Rollins Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Stifel analyst Stephen Willey reinstates Celcuity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELC#NASDAQ">CELC</a>) with a Buy and announces $30 price target.

News

Price Target

CELC

Stifel Reinstates Buy on Celcuity, Announces $30 Price Target

WIIM

ARRY

CSIQ

SEDG

SHLS

Shares of companies related to solar and wind projects are trading higher possibly after the US Senate passed the "One Big Beautiful Bill Act". The bill would allow another year for wind and solar projects to begin construction and would cut China from the supply chain.

Macro Economic Events

Econ #s

Economics

Reuters Reports U.S. Judge Blocks Trump Administration Move To Overhaul Health Agencies

One Stop Systems shares are trading higher after the company announced it secured a $5 million contract from the U.S. Navy.

Mercurity Fintech shares are trading higher on possible continued strength after the company was added to the Russell 2000 and 3000 indexes on Monday.

Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) has outperformed the market over the past 10 years by 3.33% on an annualized basis producing an average annual return of 14.82%. Currently, Walmart has a market capitalization of $781.36 billion. 
Buying $100 In WMT: If an investor had bought $100 of WMT stock 10 years ago, it would be worth $404.94 today based on a price of $97.91 for WMT at the time of writing.
<h3>Walmart's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751388320_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>JP Morgan analyst Joseph Greff upgraded Melco Resorts &amp; Entertainment Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLCO#NASDAQ">MLCO</a>) from Neutral to Overweight and raised the price target from $7.2 to $9.5. Melco Resorts shares closed at $7.23 on Monday. <a href="https://www.benzinga.com/quote/MLCO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Gena Wang upgraded the rating for Ionis Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONS#NASDAQ">IONS</a>) from Equal-Weight to Overweight and boosted the price target from $51 to $57. Ionis Pharmaceuticals shares closed at $39.51 on Monday. <a href="https://www.benzinga.com/quote/IONS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wolfe Research analyst Scott Group upgraded the rating for C.H. Robinson Worldwide, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRW#NASDAQ">CHRW</a>) from Peer Perform to Outperform. C.H. Robinson shares closed at $95.95 on Monday. <a href="https://www.benzinga.com/quote/CHRW/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Jason Haas upgraded Cintas Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) from Underweight to Equal-Weight and raised the price target from $196 to $221. Cintas shares closed at $222.87 on Monday. <a href="https://www.benzinga.com/quote/CTAS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Argus Research analyst John Staszak upgraded the rating for Nike, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) from Hold to Buy and maintained the price target of $85. Nike shares closed at $71.04 on Monday. <a href="https://www.benzinga.com/quote/NKE/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying NKE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/NKE/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="608" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01124213/image-11-1024x608.png" alt="" class="wp-image-969003" style="width:596px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01124213/image-11-1024x608.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01124213/image-11-300x178.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01124213/image-11-768x456.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/01124213/image-11.png 1105w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46192054/cramer-backs-this-mining-giant-after-1-6b-bet">Cramer Backs This Mining Giant After $1.6B Bet</a> </li>
</ul>
Photo via Shutterstock

CHRW

CTAS

IONS

Melco Resorts & Entertainment Limited - American Depositary Shares

MLCO

This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Fossil Group shares are trading higher after Maxim Group initiated coverage on the stock with a Buy rating and announced a price target of $5.

General

IBKR

Interactive Brokers Group Reports 3.448 Million Daily Average Revenue Trades In June, 40% Higher Than Prior Year And 2% Higher Than Prior Month

VRCA

Verrica Pharmaceuticals shares are trading higher after the company announced a second amendment to its existing collaboration and licensing agreement with Torii Pharmaceutical to initiate Phase 3 of the Ycanth trial.

Market Summary

TSLA

Benzinga Market Summary: Senate Passes Spending Bill, Tesla Falls On Trump-Musk Tensions And Lower Registrations In Sweden And Denmark, Nike Rises On Argus Upgrade

HTCR

Heartcore Enterprises shares are trading lower. The company announced it entered into a securities and equities purchase agreement to issue up to 2,000 shares of series A convertible preferred stock.

Piper Sandler analyst Crispin Love maintains PennyMac Financial Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFSI#NYSE">PFSI</a>) with a Overweight and lowers the price target from $128 to $125.

PFSI

Piper Sandler Maintains Overweight on PennyMac Financial Servs, Lowers Price Target to $125

Public companies continued to expand their Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) holdings at a faster pace than <a href="https://www.benzinga.com/money/best-spot-bitcoin-etfs">exchange-traded funds</a> (ETFs) for the third consecutive quarter, signaling a growing corporate interest in holding Bitcoin directly.
What Happened: Data from Bitcoin Treasuries shows that public companies acquired approximately 131,000 BTC in the second quarter of 2025, marking an 18% increase in their total Bitcoin holdings, <a href="https://www.cnbc.com/2025/07/01/public-companies-bought-more-bitcoin-than-etfs-did-for-the-third-quarter-in-a-row.html">according</a> to CNBC.
By comparison, ETFs added around 111,000 BTC during the same period, reflecting an 8% rise.
Analysts note that corporate Bitcoin buyers are often motivated by a different set of priorities than institutional ETF investors. 
According to Nick Marie, head of research at Ecoinometrics, while ETF investors seek exposure to Bitcoin's price movements, companies acquiring Bitcoin for their treasuries are focused on long-term accumulation to enhance shareholder value.
Marie highlighted that corporate Bitcoin holdings grew 4% in April, despite market volatility triggered by President Donald Trump's tariff announcements.
ETFs, by contrast, saw only a 2% increase during the same period. 
He added that for these companies, the price of Bitcoin is not the primary driver, what matters is building substantial reserves that appeal to indirect Bitcoin investors.
ETFs remain the largest single holders of Bitcoin, with combined assets exceeding 1.4 million BTC, accounting for roughly 6.8% of the cryptocurrency's fixed supply. 
Public companies currently hold about 855,000 BTC, or 4% of total supply.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46194028/bitcoin-to-hit-200000-in-2025-but-new-eth-sol-highs-remain-in-doubt-bitwise-says">Bitcoin To Hit $200,000 In 2025, But New ETH, SOL Highs Remain In Doubt, Bitwise Says</a>
Why It Matters: The shift in buying patterns comes amid a more favorable regulatory climate for crypto under the Trump administration. 
In March, President Trump signed an executive order establishing a U.S. Bitcoin reserve, a move widely seen as solidifying Bitcoin's place in the financial system. 
The last time ETFs outpaced corporate treasuries in Bitcoin accumulation was in the third quarter of 2024.
Several notable companies joined the Bitcoin treasury trend in the second quarter. 
GameStop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) approved Bitcoin as a treasury reserve asset in March. 
KindlyMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAKAW#NASDAQ">NAKAW</a>), a healthcare firm, merged with Nakamoto, a Bitcoin investment company founded by David Bailey. 
ProCap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAPU#NASDAQ">PCAPU</a>), led by investor Anthony Pompliano, began purchasing Bitcoin and is preparing to go public via a special purpose acquisition company (SPAC).
Strategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), formerly known as MicroStrategy, remains the largest corporate Bitcoin holder with about 597,000 BTC. Bitcoin miner Mara Holdings is the second-largest, holding close to 50,000 BTC. 
Ben Werkman, chief investment officer at Swan Bitcoin, said Strategy's scale will be difficult for other companies to match, particularly given the liquidity surrounding its stock. 
Smaller Bitcoin treasury companies, however, could offer attractive risk-reward opportunities for investors looking to capitalize on earlier growth phases.
Marie suggested the number of companies following the Bitcoin treasury strategy could decline over the next decade. 
He explained that as more firms adopt this approach, the unique appeal may diminish, especially if Bitcoin becomes more accessible to traditional investors without the need for intermediaries.
Werkman noted that Bitcoin treasury companies offer a distinct advantage for investors seeking to outperform Bitcoin's price: the ability to leverage capital markets to accumulate additional Bitcoin. 
He also pointed out that some companies may eventually convert their treasury holdings to Bitcoin without adopting the aggressive, leveraged strategy that has defined Strategy's approach.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46178713/new-bitcoin-backed-stablecoin-vaults-offer-yield-strategies-without-requiring-btc-sales">New Bitcoin-Backed Stablecoin Vaults Offer Yield Strategies Without Requiring BTC Sales</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

MSTR

NAKAW

PCAPU

Public Companies Are Quietly Building Massive Bitcoin Treasuries Faster Than ETFs Can Keep Up

Piper Sandler analyst Crispin Love maintains Ellington Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFC#NYSE">EFC</a>) with a Overweight and lowers the price target from $15 to $14.5.

Piper Sandler Maintains Overweight on Ellington Financial, Lowers Price Target to $14.5

Bank of America Securities analyst Justin Post <a href="https://www.benzinga.com/quote/AMZN/analyst-ratings" target="_blank" rel="noreferrer noopener">maintained a Buy</a> rating on Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a price forecast of $248 on Tuesday.
Amazon&#8217;s 11th Prime Day event kicks off on July 8 and extends for 4 days, double last year&#8217;s 2-day event, but will offer early access promotions like the previous year, Post noted.
The analyst said the event offers millions of deals on 35+ categories spanning electronics, fashion, and personal care, as well as savings on Amazon&#8217;s less penetrated categories like grocery, gasoline, and travel.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/45982631/amazon-ceo-says-generative-ai-will-reduce-total-corporate-workforce" rel="noreferrer noopener">Amazon CEO Says Generative AI Will Reduce Total Corporate Workforce</a>
Prime Day will be held in 26 countries, including six that start later this summer (likely for better timing).
Amazon positioned AI as a key savings tool in its latest Prime release, aligning with Post&#8217;s view that AI boosts retail efficiency and transparency.
Post said U.S. shoppers can now use Alexa+ to track price drops, get personalized deals, and receive AI-powered recommendations via Rufus and Shopping Guides.
The analyst predicts that Prime Day will extend twice as long this year and will, therefore, impact year-over-year (Y/Y) trends.
For the 4-day event, he projected 55% Y/Y first-party growth to $11.5 billion and 67% Y/Y third-party growth to $10.0 billion. Post estimated Prime Day could generate $21.4 billion in Gross Merchandise Value (GMV), growing approximately 60% Y/Y.
The analyst&#8217;s estimate implied $5.4 billion in GMV daily, down 20% Y/Y, which is reasonable given less urgency around each day.
Based on his projection for $208 billion in total third-quarter GMV, he estimated Prime Day(s) could represent 10.3% of GMV for the quarter (higher than 7.0% last year).
Despite competition from retailers like Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>), Target Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>), and Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>), Post expects the event to remain a positive driver for Amazon branding and Prime sign-up/retention.
Extending the savings window suggests that Amazon has greater retail logistics capacity to offer promotions, and that inventory availability is not a constraint, despite tariff concerns, as per the analyst.
Price Action:&nbsp;AMZN stock is down 0.28% at $218.76 at the last check on Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46149318/microsofts-next-gen-ai-chip-still-lags-nvidias-blackwell-postpones-launch" target="_blank" rel="noreferrer noopener">Microsoft&#8217;s Next-Gen AI Chip Still Lags Nvidia&#8217;s Blackwell, Postpones Launch</a></li>
</ul>
Image via Shutterstock

Reiteration

Tech

AMZN

Amazon's AI-Powered 4-Day Prime Day Will Drive Billions In Sales

MBIO

Mustang Bio shares are trading higher after the company announced it received FDA Orphan Drug designation status for MB-101.

Piper Sandler analyst Crispin Love maintains Mr. Cooper Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COOP#NASDAQ">COOP</a>) with a Neutral and raises the price target from $143 to $158.

COOP

Piper Sandler Maintains Neutral on Mr. Cooper Gr, Raises Price Target to $158

The <a href="https://www.benzinga.com/topic/dow-jones-industrial-average">Dow Jones Industrial Average</a> was up around 4% in the first half of 2025, with 21 of the 30 components positive year-to-date through the first six months.
The index, which contains a diverse basket of stocks across sectors, offers many dividend stocks, with some having high yields for investors.
What Happened: When looking <a href="https://www.benzinga.com/dividends">for dividend stocks</a>, the Dow Jones Industrial Average is one place with the index having a basket of what are considered blue-chip American companies.
The 30 index components have strong track records of revenue and earnings growth, and in many cases, a long history of paying dividends and raising the dividend amounts.
While investors can buy an ETF like the SPDR Dow Jones Industrial Average ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>), which tracks the entire index, another option is to buy the &#8220;Dogs of the Dow.&#8221;
The "Dogs of the Dow" is a popular strategy that often coincides with the beaten-down stocks of the index which also offer high dividend payouts.
Here are the current top-yielding dividend stocks in the Dow Jones Industrial Average after the first six months of 2025.
<ol class="wp-block-list">
<li>Verizon Communications Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>): 6.3%</li>
<li>Chevron Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>): 4.8%</li>
<li>Merck &amp; Co Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>): 4.1%</li>
<li>Amgen Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>): 3.4%</li>
<li>Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>): 3.4%</li>
<li>Coca-Cola Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>): 2.9%</li>
<li>UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>): 2.8%</li>
<li>Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>): 2.7%</li>
<li>Home Depot Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>): 2.5%</li>
<li>McDonald's Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>): 2.4%</li>
</ol>
In the Dow Jones Industrial Average, 28 of the 30 stocks pay out dividends. The average dividend yield of the 30 companies is 2% with the 10 highest averaging a yield of 3.5%.
Twenty of the 30 stocks in the index pay out at least a 1% dividend yield based on current stock prices.
Read Also: <a href="https://www.benzinga.com/markets/large-cap/25/07/46200141/dow-jones-2025-first-half-scoreboard-top-10-winners-losers-where-do-nvidia-apple-stock-rank">Dow Jones 2025 First Half Scoreboard: Top 10 Winners, Losers — Where Do Nvidia, Apple Stock Rank?</a>
Why It's Important: Along with stock price gains, dividends can be a nice form of consistent growth for companies and investors.
Investors can choose to collect dividend yield and put the capital to work in other stocks, or use it as income for other investments or spending. Investors can also reinvest the dividends back into the companies from which they got dividends.
Over a long period of time, dividend stocks can offer strong returns for investors with yields sometimes outpacing the returns of the overall stock market or other asset classes such as bonds and treasuries.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/best-monthly-dividend-stocks">Best Monthly Dividend Stocks</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Education

Dividends

AMGN

SPDR Dow Jones Industrial Average ETF Trust

Dogs Of The Dow: How You Can Get Dividend Stocks With Yields Up To 6.3%

Press Releases

China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency

China SXT Pharmaceuticals, Inc. Announces Share Consolidation

China SXT Pharmaceuticals Has Regained Compliance with Nasdaq's Minimum Bid Price Deficiency

Comments

China SXT Pharmaceuticals

Noticias

Últimas noticias sobre China SXT Pharmaceuticals (NASDAQ:SXTC) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL